Ventyx Biosciences

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$1,076
Gross Profit
-316
-408
673
EBITDA
-35,396
-41,360
-49,943
EBIT
-35,712
-41,768
-50,346
Net Income
-31,950
-38,572
-46,753
Net Change In Cash
0
0
1,076
Free Cash Flow
-24,598
-47,800
-51,866
Cash
40,925
141,898
51,579
Basic Shares
70,554
61,829
59,076

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-941
-470
-30
EBITDA
-207,836
-107,956
-67,117
-7,051
EBIT
-207,994
-108,426
-67,147
-14,101
Net Income
-192,962
-107,956
-78,366
-28,532
Net Change In Cash
0
0
0
0
Cost of Revenue
-5,930
70,547
Free Cash Flow
-167,036
-99,046
-38,912
-6,195
Cash
51,579
64,819
70,791
244
Basic Shares
58,542
52,471
50,408
50,296

Earnings Calls

Quarter EPS
2024-09-30
-$0.50
2024-06-30
-$0.45
2024-03-31
-$0.62
2023-12-31
-$0.79